Study design of early clinical trials and development strategy of targeted anticancer agents approved by FDAQIN Lu, LIU Shui, ZHAO Di, LIU Chuan, ZHOU Fa-jun129-134
Starred pharmaceutical patent layout of world-renowned pharmaceutical enterprises: revelation for Chinese pharmaceutical enterprisesXIAO Han, ZHU Min-tian, ZHANG Si-wen135-141
Betrixaban: a novel oral anticoagulant (NOAC)ZHANG Chi, SHEN Long, LIU Xiao-yan, GU Zhi-chun, PAN Mang-mang142-145
Discussion on some problems of specification statements of traditional Chinese medicinesSUN Yu, HAN Wei146-150
Protection of puerarin on microvascular endothelial cells in ischemic penumbra of rats with focal cerebral ischemia and possible mechanismXUE Qiang, CHEN Hong, ZHOU Jia-li, JIANG Hong-yan, ZHENG Xiao-hong, YANG Yan-yin, DENG Qing-hua, XU Xiao-yu151-158
Safety and toxicological evaluation of human umbilical cord mesenchymal stem cellsTIAN Yi-chao, ZHOU Duan-peng, CUI Yan-jun, ZHANG Ya-qi, LIU Meng-jie, RAO Wei, ZHANG Quan, FANG Pan, PANG Cong, CEN Yu-jie, HAN Bing, WU Dong-cheng159-163
Clinical application and research progress of ALK-TKIs in the treatment of non-small cell lung cancerSUN Dan-tong, HOU He-lei, ZHANG Xiao-chun164-172
Advances in pharmacological study of dihydromyricetinCHEN Ya-li, YIN Yue-fei, LI Yun, ZHANG De-kui173-178
Treatment of functional dyspepsia in children with WangshiBaochi Pills: a randomized double-blind multicenter clinical trialHU Si-yuan, MA Rong, GUANG Jun-xiu, FENG Zi-wei, XU Hui-fu, LI Xue-ming, BAI Xiao-hong, MA Qing-ping, XIANG Xi-xiong, ZHU Feng-lian, LI Wei-wei, LIU Ping-ding, CAI Jian-xin, ZHANG Hui179-183
Antibacterial activities of different hydrolyzed peptides of recombinant hemoglobin from UrechisunicinctusNIU Rong-li, YE Gui-hua, CHENG Luo-yao, ZHANG Yun-rui, PAN Jin-fen184-189